Bicara Therapeutics Inc. - 10-Q Filing
Bicara Therapeutics Inc. filed its quarterly report for the period ended March 31, 2026, disclosing financial results and operational updates as a clinical-stage biopharmaceutical company.
Tickers: $BCAX
Bicara Therapeutics Inc. filed its quarterly report for the period ended March 31, 2026, disclosing financial results and operational updates as a clinical-stage biopharmaceutical company.
Tickers: $BCAX